The acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2FDTQR8
via IFTTT
The acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.
No comments:
Post a Comment